Behavioral Recovery in MPTP-Treated Monkeys: Neurochemical Mechanisms Studied by Intrastriatal Microdialysis
Open Access
- 17 September 2008
- journal article
- research article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 28 (38) , 9575-9584
Abstract
Parkinson's disease (PD) patients express motor symptoms only after 60–80% striatal dopamine (DA) depletion. The presymptomatic phase of the disease may be sustained by biochemical modifications within the striatum. We used an appropriate specific1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) monkey model (Mounayar et al., 2007) to study the compensatory mechanisms operating in recovery from PD motor symptoms. We assessed the levels of DA and its metabolites (DOPAC, homovanillic acid), GABA, glutamate (Glu), serotonin (5-HT) and its metabolite (5HIAA) by repeated intracerebral microdialysis in awake animals before exposure to MPTP during full expression of the motor symptoms induced by MPTP and after recovery from these symptoms. Measurements were obtained from two functionally and anatomically different striatal areas: the associative-limbic territory and sensorimotor territory. Animals with motor symptoms displayed an extremely large decrease in levels of DA and its metabolites and an increase in Glu and GABA levels, as reported by other studies. However, we show here for the first time that serotonin levels increased in these animals. We found that increases in DA levels in the sensorimotor and/or associative-limbic territory and high levels of 5-HT and of its metabolite, 5HIAA, were associated with recovery from motor symptoms in this model. Determining whether similar changes in DA and 5-HT levels are involved in the compensatory mechanisms delaying the appearance of motor symptoms in the early stages of PD might make it possible to develop new treatment strategies for the disease.Keywords
This publication has 57 references indexed in Scilit:
- A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recoveryBrain, 2007
- Behavioral motor recovery in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐lesioned squirrel monkey (Saimiri sciureus): Changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteinsJournal of Neuroscience Research, 2005
- Chemical neuroanatomy of the basal ganglia — normal and in Parkinson's diseaseJournal of Chemical Neuroanatomy, 2001
- Dopaminergic innervation of the pallidum in the normal state, in MPTP-treated monkeys and in parkinsonian patientsEuropean Journal of Neuroscience, 2000
- Chronic exposure to low doses of MPTP. II. Neurochemical and pathological consequences in cognitively-impaired, motor asymptomatic monkeysBrain Research, 1990
- In vivo changes of catecholamines in hemiparkinsonian monkeys measured by microdialysisExperimental Neurology, 1990
- Methodology of microdialysis of neostriatum in hemiparkinsonian nonhuman primatesExperimental Neurology, 1990
- Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTPNeuroscience Letters, 1989
- Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's DiseaseNew England Journal of Medicine, 1988
- CGS 10746B: An atypical antipsychotic candidate that selectively decreases dopamine release at behaviorally effective dosesLife Sciences, 1986